{"DataElement":{"publicId":"7799632","version":"1","preferredName":"Colorectal Cancer AJCC Edition 8 Group Stage","preferredDefinition":"Stage group based on the combination of T, N, and M categories and relevant prognostic factors for colon and rectal carcinoma, using AJCC Ed. 8 criteria to include Stage II.","longName":"2769361v1.0:7799631v1.0","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"2769361","version":"1","preferredName":"Colorectal Tumor Stage Grouping","preferredDefinition":"information related to stage grouping, an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, assessment of a colorectal neoplasm.","longName":"COLO_TUM_STG","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206583","version":"1","preferredName":"Colorectal Neoplasm","preferredDefinition":"(ko-lo-REK-tul) Having to do with the colon or the rectum.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C13363:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal","conceptCode":"C13363","definition":"Relating to the colon and rectum, or to the entire large bowel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FAFA-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"532E1334-9D26-1F6C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-29","modifiedBy":"TAYLORT","dateModified":"2019-08-28","changeDescription":"8-28-19 ownership transfer approved by CTEP/B.Campbell; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7799631","version":"1","preferredName":"Colorectal Carcinoma American Joint Committee on Cancer Edition 8 Group Stage","preferredDefinition":"A term that refers to the staging of colorectal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to adenocarcinomas, high-grade neuroendocrine carcinomas, and squamous cell carcinomas of the colon and rectum. Appendiceal carcinomas, anal carcinomas, and well-differentiated neuroendocrine tumors (carcinoids) are not covered by this staging system. (from AJCC 8th Ed.)._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"7799631v1.0","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"II","valueDescription":"Stage II Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"5913676","version":"1","preferredName":"Stage II Colorectal Cancer AJCC v8","longName":"5913676","preferredDefinition":"Stage II includes: IIA: T3, N0, M0; IIB: T4a, N0, M0; IIC: T4b, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Colorectal Cancer AJCC v8","conceptCode":"C134186","definition":"Stage II includes: IIA: T3, N0, M0; IIB: T4a, N0, M0; IIC: T4b, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5499ACEF-111D-1155-E053-F662850A3955","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-3904-31AA-E053-4EBD850A74F3","beginDate":"2021-10-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"6866846","version":"1","preferredName":"Stage 0 Colorectal Cancer AJCC v8","longName":"6866846","preferredDefinition":"Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ, intramucosal carcinoma (involvement of lamina propria with no extension through muscularis mucosae). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Colorectal Cancer AJCC v8","conceptCode":"C134182","definition":"Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ, intramucosal carcinoma (involvement of lamina propria with no extension through muscularis mucosae). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912CD09F-1E38-701A-E053-F662850A3FC3","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-390E-31AA-E053-4EBD850A74F3","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"5913678","version":"1","preferredName":"Stage I Colorectal Cancer AJCC v8","longName":"5913678","preferredDefinition":"Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Colorectal Cancer AJCC v8","conceptCode":"C134185","definition":"Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5499ACEF-1143-1155-E053-F662850A3955","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-3918-31AA-E053-4EBD850A74F3","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"6866868","version":"1","preferredName":"Stage IIA Colorectal Cancer AJCC v8","longName":"6866868","preferredDefinition":"Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Colorectal Cancer AJCC v8","conceptCode":"C134187","definition":"Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912DD9D1-A9D7-72DF-E053-F662850A43D9","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-3922-31AA-E053-4EBD850A74F3","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"6866866","version":"1","preferredName":"Stage IIB Colorectal Cancer AJCC v8","longName":"6866866","preferredDefinition":"Stage IIB includes: T4a, N0, M0. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Colorectal Cancer AJCC v8","conceptCode":"C134188","definition":"Stage IIB includes: T4a, N0, M0. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912DD9D1-A9B1-72DF-E053-F662850A43D9","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-392C-31AA-E053-4EBD850A74F3","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"IIC","valueDescription":"Stage IIC Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"6866864","version":"1","preferredName":"Stage IIC Colorectal Cancer AJCC v8","longName":"6866864","preferredDefinition":"Stage IIC includes: T4b, N0, M0. T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIC Colorectal Cancer AJCC v8","conceptCode":"C134190","definition":"Stage IIC includes: T4b, N0, M0. T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912DD9D1-A98B-72DF-E053-F662850A43D9","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-3936-31AA-E053-4EBD850A74F3","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"6866862","version":"1","preferredName":"Stage IIIA Colorectal Cancer AJCC v8","longName":"6866862","preferredDefinition":"Stage IIIA includes: (T1-T2, N1/N1c, M0); (T1, N2a, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2a: Four to six regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Colorectal Cancer AJCC v8","conceptCode":"C134192","definition":"Stage IIIA includes: (T1-T2, N1/N1c, M0); (T1, N2a, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2a: Four to six regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912DD9D1-A965-72DF-E053-F662850A43D9","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-3940-31AA-E053-4EBD850A74F3","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"6866860","version":"1","preferredName":"Stage IIIB Colorectal Cancer AJCC v8","longName":"6866860","preferredDefinition":"Stage IIIB includes: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Colorectal Cancer AJCC v8","conceptCode":"C134193","definition":"Stage IIIB includes: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912DD9D1-A93F-72DF-E053-F662850A43D9","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-394A-31AA-E053-4EBD850A74F3","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Stage IIIC Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"6866858","version":"1","preferredName":"Stage IIIC Colorectal Cancer AJCC v8","longName":"6866858","preferredDefinition":"Stage IIIC includes: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N2: Four or more regional lymph nodes are positive. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC Colorectal Cancer AJCC v8","conceptCode":"C134194","definition":"Stage IIIC includes: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N2: Four or more regional lymph nodes are positive. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912DD9D1-A919-72DF-E053-F662850A43D9","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-3954-31AA-E053-4EBD850A74F3","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"6866856","version":"1","preferredName":"Stage IVA Colorectal Cancer AJCC v8","longName":"6866856","preferredDefinition":"Stage IVA includes: Any T, Any N, M1a. M1a: Metastasis to one site or organ without peritoneal metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Colorectal Cancer AJCC v8","conceptCode":"C134196","definition":"Stage IVA includes: Any T, Any N, M1a. M1a: Metastasis to one site or organ without peritoneal metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912DD9D1-A8F3-72DF-E053-F662850A43D9","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-395E-31AA-E053-4EBD850A74F3","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"IVB","valueDescription":"Stage IVB Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"6866854","version":"1","preferredName":"Stage IVB Colorectal Cancer AJCC v8","longName":"6866854","preferredDefinition":"Stage IVB includes: Any T, Any N, M1b. M1b: Metastasis to two or more sites or organs without peritoneal metastasis.  (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Colorectal Cancer AJCC v8","conceptCode":"C134197","definition":"Stage IVB includes: Any T, Any N, M1b. M1b: Metastasis to two or more sites or organs without peritoneal metastasis.  (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912DD9D1-A8CD-72DF-E053-F662850A43D9","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-3968-31AA-E053-4EBD850A74F3","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"IVC","valueDescription":"Stage IVC Colorectal Cancer AJCC v8","ValueMeaning":{"publicId":"6866852","version":"1","preferredName":"Stage IVC Colorectal Cancer AJCC v8","longName":"6866852","preferredDefinition":"Stage IVC includes: Any T, Any N, M1c. M1c: Metastasis to the peritoneal surface alone or with other site or organ metastases. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVC Colorectal Cancer AJCC v8","conceptCode":"C134198","definition":"Stage IVC includes: Any T, Any N, M1c. M1c: Metastasis to the peritoneal surface alone or with other site or organ metastases. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912DD9D1-A8A7-72DF-E053-F662850A43D9","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF47EF6-3972-31AA-E053-4EBD850A74F3","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6866843","version":"1","preferredName":"Colorectal Cancer by AJCC v8 Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the staging of colorectal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to adenocarcinomas, high-grade neuroendocrine carcinomas, and squamous cell carcinomas of the colon and rectum. Appendiceal carcinomas, anal carcinomas, and well-differentiated neuroendocrine tumors (carcinoids) are not covered by this staging system. (from AJCC 8th Ed.):An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C134180:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal Cancer by AJCC v8 Stage","conceptCode":"C134180","definition":"A term that refers to the staging of colorectal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to adenocarcinomas, high-grade neuroendocrine carcinomas, and squamous cell carcinomas of the colon and rectum. Appendiceal carcinomas, anal carcinomas, and well-differentiated neuroendocrine tumors (carcinoids) are not covered by this staging system. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912CD09F-1E0B-701A-E053-F662850A3FC3","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF47EF6-38EC-31AA-E053-4EBD850A74F3","latestVersionIndicator":"Yes","beginDate":"2021-10-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"BOWSERC","dateModified":"2021-12-03","changeDescription":"TL and CB created for GI008.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease stage AJCC 8th:","type":"Preferred Question Text","description":"Disease stage AJCC 8th:","url":null,"context":"NRG"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF4A696-E598-77B4-E053-4EBD850AE3B8","latestVersionIndicator":"Yes","beginDate":"2021-10-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-10-22","modifiedBy":"BOWSERC","dateModified":"2021-12-03","changeDescription":"TL and CB created for GI008.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}